Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Breast 8Gastrointestinal 7Thoracic 6Genitourinary 5Other solid neoplasm 4Other hematologic neoplasm 4Lymphoid 4Other 2Plasma cell 1Other neoplasm 1Head & Neck 1Gynecologic 1Dermatologic 1

Conditions

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1

Interventions

Paclitaxel 575Carboplatin 520Cisplatin 347Bevacizumab 252pembrolizumab 226Gemcitabine 157Topotecan 128liposomal doxorubicin 127Cyclophosphamide 126olaparib 120Taxes 113Radiotherapy 110Docetaxel 94Brachytherapy 89Doxorubicin 84Drug Therapy 80niraparib 75Nivolumab 71Magnetic Resonance Spectroscopy 71Specimen Handling 65fludarabine 56Biopsy 55Hyperthermic Intraperitoneal Chemotherapy 53Filgrastim 52Letrozole 50Oxaliplatin 48durvalumab 47Immunoglobulin G 47atezolizumab 46Platinum 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Exercise Test × Gynecologic × Clear all
NCT06213571 2026-01-09

Remote Home-Based Exercise Program for Strength Training in Endometrial Cancer Survivors in Rural Areas

Mayo Clinic

Phase NA Active not recruiting
80 enrolled
Gynecologic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡